Technology Journal of Ohio: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Journal of Ohio.

Press releases published on October 22, 2026

an hour ago

P-Protect Patch Introduces P Protect Prostate Patch for Men’s Wellness Support

Indeterminate GlobeNewswire

an hour ago

CORRECTION -- Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans

Indeterminate GlobeNewswire

an hour ago

VisCardia Announces Publication of RECOVER-HF Pilot Trial in JACC: Heart Failure

Indeterminate GlobeNewswire

an hour ago

IBEX Limited to Announce First Quarter 2027 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

an hour ago

Forge Nano Lists on NASDAQ, Bringing Atomic-Scale Innovation to American Semiconductor and Battery Manufacturing

Indeterminate GlobeNewswire

an hour ago

BlackLine Announces Date for Third Quarter 2026 Earnings Release and Conference Call

Indeterminate GlobeNewswire

an hour ago

Turtle Beach Corporation to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026

Indeterminate GlobeNewswire

an hour ago

SoundHound AI to Announce Third Quarter 2026 Financial Results on November 5th

Indeterminate GlobeNewswire

an hour ago

BNB Standard Corporation Appoints Margaret Rosenfeld as Executive Vice President, Chief Strategy and Legal Officer

Indeterminate GlobeNewswire

an hour ago

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

an hour ago

Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development

Indeterminate GlobeNewswire

an hour ago

Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data

Indeterminate GlobeNewswire

an hour ago

Telitacicept Demonstrates Durable Preservation of Kidney Function Through Two Years in Phase 3 TELIGAN Trial in IgA Nephropathy

Indeterminate GlobeNewswire

an hour ago

BGSF, Inc. Announces Timing of Fiscal 2026 Third Quarter Results and Earnings Conference Call

Indeterminate GlobeNewswire

an hour ago

AppFolio, Inc. Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

an hour ago

Kiniksa Pharmaceuticals to Report Third Quarter 2026 Financial Results on October 27, 2026

Indeterminate GlobeNewswire

an hour ago

Kymera Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026

Indeterminate GlobeNewswire

an hour ago

Ligand to Host Investor Day on December 8, 2026

Indeterminate GlobeNewswire

an hour ago

Big Digital Energy to Release Third Quarter 2026 Results November 5th

Indeterminate GlobeNewswire

an hour ago

Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026

Indeterminate GlobeNewswire